首页 | 本学科首页   官方微博 | 高级检索  
检索        

肾癌根治术患者手术前后CD8+CD28-T细胞表达及临床意义
引用本文:李华强,袁坚,唐云峰,陈少娜.肾癌根治术患者手术前后CD8+CD28-T细胞表达及临床意义[J].岭南现代临床外科,2015,15(2):219-221.
作者姓名:李华强  袁坚  唐云峰  陈少娜
作者单位:1. 广东医学院附属廉江市人民医院泌尿外科; 2. 广州医学院第一附属医院
摘    要:【摘要】〓目的〓探讨肾癌根治术患者手术前后CD8+CD28-T细胞表达及临床意义。方法〓收集52例接受根治术的肾癌患者作为观察对象,采用流式细胞术检测手术前后外周血CD8+CD28-T细胞、白介素10(IL-10)及转化生长因子β1(TGF-β1)含量;分析三者含量与肿瘤分期的相关性,并以肾错构瘤患者及正常人作为对照。结果〓肾癌患者CD8+CD28-T细胞、IL-10及TGF-β1均显著高于另外两组,但肾错构瘤患者与正常人之间均无统计学差异(P<0.05);术前III期患者CD8+CD28-T细胞、IL-10及TGF-β1显著高于I及II期(P<0.05);术后各期肾癌患者CD8+CD28-T细胞及TGF-β1含量均显著低于术前(P<0.05),但IL-10却与术前无统计学差异;术后III期患者CD8+CD28-T细胞、IL-10及TGF-β1显著高于Ⅰ及Ⅱ期患者(P<0.05),但术前及术后I及II期患者上述三项指标均无统计学差异。相关性分析显示CD8+CD28-T细胞、IL-10及TGF-β1与分期均呈显著正相关性(P<0.05),其相关程度由大至小依次为CD8+CD28-T细胞>TGF-β1>IL-10。结论〓CD8+CD28-T细胞及其细胞因子表达含量增多可能是肾癌的一个新免疫机制,前者可在一定程度上鉴别肾癌与良性肿瘤,且可以评价手术效果。

关 键 词:肾癌  CD8+CD28-T细胞  分期  流式细胞术  

Expression and clinical significance of CD8+CD28-T cells for renal carcinoma patients underwent nephrectomy
Li Huaqiang,Yuan Jian,Tang Yunfeng,Chen Shaona.Expression and clinical significance of CD8+CD28-T cells for renal carcinoma patients underwent nephrectomy[J].Lingnan Modern Clinics in Surgery,2015,15(2):219-221.
Authors:Li Huaqiang  Yuan Jian  Tang Yunfeng  Chen Shaona
Institution:Li Huaqiang;Yuan Jian;Tang Yunfeng;Chen Shaona;Department of Urinary Surgery, the Affiliated Lianjiang People’s Hospital of Guangdong Medical College;Department of Urinary Surgery , the First Affiliated Hospital , Guangzhou Medical University;
Abstract:【Abstract】〓Objective〓To investigate the expression and clinical significance of CD8+CD28-T cells for patients with renal carcinoma undergoing nephrectomy. Methods〓Fifty-two patients who underwent radical prostatectomy were collected as research objects (group A). Flow cytometry was used to test peripheral blood CD8+CD28-T cells before and after operation, interleukin 10 (IL-10), and transforming growth factor beta 1 (TGF-beta 1) content. The correlation between the three levels and of tumor stage was analyzed. The patients with renal hamartoma (group B) and normal people (group C) served as controls. Results〓The CD8+CD28-T cells number, expression of IL-10 and TGF-beta 1 in group A were significantly higher than the other two groups, but had no statistical difference between the group B and group C. Preoperative levels of CD8+CD28-T cells, IL-10 and TGF-beta 1 in the patients with stage III were significantly higher than those with stage I and stage II(P<0.05). Postoperative levels of CD8+CD28-T cells,IL-10 were increased and TGF-beta 1 content was decreased in patients with stage III than that of preoperative period (P<0.05), but no difference in patients with stage I and stage II between pre- and post-operation. Correlation analysis showed that the CD8+CD28-T cells, IL-10 and TGF-beta 1 and tumor stage showed significant positive correlation (P<0.05) and the related degree was CD8+CD28-T cells > TGF-beta 1> IL-10. Conclusion〓The increases of CD8+CD28-T cells and cytokines levels could be a new immune mechanism of kidney carcinoma, and the former could identify kidney cancer and benign tumor, evaluate the operation effect.
Keywords:Renal carcinoma  CD8+CD28-T cells  Tumor Stage  Flow cytometry
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《岭南现代临床外科》浏览原始摘要信息
点击此处可从《岭南现代临床外科》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号